Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | MBS301 |
Synonyms | |
Therapy Description |
MBS301 is a bi-specific antibody that simultaneously recognizes two domains of ERBB2 (HER2), potentially resulting in antibody-dependent cell-mediated cytoxicity and decreased proliferation of ERBB2 (HER2)-expressing tumor cells (PMID: 30081724). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MBS301 | MBS-301|MBS 301 | HER2 (ERBB2) Antibody 72 | MBS301 is a bi-specific antibody that simultaneously recognizes two domains of ERBB2 (HER2), potentially resulting in antibody-dependent cell-mediated cytoxicity and decreased proliferation of ERBB2 (HER2)-expressing tumor cells (PMID: 30081724). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|